On September 19, 2023 Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase ib Clinical Trial Targeting Healthy Young Women
On December 2, 2022 Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines
On December 1, 2022 Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge one year later
On November 9, 2022 Vaccine Development: From Concept to Clinic, Chapter 10: Vaccine Adjuvants: Mechanisms of Action
On November 8, 2022 Lyophilization process engineering and thermostability of ID93 + GLA-SE, a single-vial adjuvanted subunit tuberculosis vaccine candidate for use in clinical studies
